Clinical Application of Cataract Ultrasonic Emulsification Combined with Atrial Angle Segmentation in the Treatment of Primary Angle-Closure Glaucoma

Objective: To evaluate the therapeutic effect of cataract ultrasonic emulsification (PE) combined with atrial angle separation (CSS) for primary angle-closure glaucoma (PACG). Methods: 78 patients with PACG admitted to the hospital between October 2021 and October 2023 were selected and grouped by randomized numerical table; 39 cases were counted in the observation group and selected PE combined with CSS surgery; 39 cases were counted in the reference group and selected PE combined with trabeculectomy and the total effective rate, the state of the atrial angle, the clinical indexes, the degree of ocular symptoms, and the complication rate were compared. Results: The total effective rate of the observation group was higher than that of the reference group, and the percentage of the wide atrial angle of the atrial angle status was higher than that of the reference group; 3 months after the operation, the logarithm of the minimum angle of resolution (Log MAR) and intraocular pressure of the observation group was lower than that of the reference group, and the central anterior chamber depth (ACD) was greater than that of the reference group; the scores of the degree of ocular symptoms of the observation group were lower than that of the reference group, and the rate of complication was lower than that of the reference group (P < 0.05). Conclusion: PE combined with CSS surgical treatment for PACG patients can improve the efficacy of treatment, improve the state of the patients’ atrial angles, and restore the ocular function indexes. It can alleviate the ocular symptoms as soon as possible and has a high surgical safety.